J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers and D. M. Parkin, “Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, Vol. 127, No. 12, 2010, pp. 2893-2917. http://dx.doi.org/10.1002/ijc.25516
 T. R. Rebbeck, S. S. Devesa, B.-L. Chang, et al., “Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent,” Prostate Cancer, Vol. 2013, 2013, Article ID: 560857. http://dx.doi.org/10.1155/2013/560857
 F. A. Kabore, T. Kambou, B. Zango and A. Ouédraogo, “Knowledge and Awareness of Prostate Cancer among the General Public in Burkina Faso,” Journal of Cancer Education, 2013, in press.
 F. A. Kabore, B. Zango, A. Sanou, C. Yameogo and B. Kirakoya, “Prostate Cancer Outcome in Burkina Faso,” Infectious Agents and Cancer, Vol. 6, Suppl. 2, 2011, p. S6.
 E. Chokunonga, M. Z. Borok, Z. M. Chirenje, A. M. Nyakabau and D. M. Parkin, “Trends in the Incidence of Cancer in the Black Population of Harare, Zimbabwe 1991-2010,” International Journal of Cancer, Vol. 133, No. 3, 2013, pp. 721-729. http://dx.doi.org/10.1002/ijc.28063
 G. O. Ifere, F. Abebe and G. A. Ananaba, “Emergent Trends in the Reported Incidence of Prostate Cancer in Nigeria,” Clinical Epidemiology, Vol. 4, No. 1, 2012, pp. 19-32.
 J. Yarney, V. Vanderpuye and J. Mensah, “Clinicopathologic Features and Determinants of Gleason Score of Prostate Cancer in Ghanaian Men,” Urologic Oncology: Seminars and Original Investigations, Vol. 31, No. 3, 2013, pp. 325-330. http://dx.doi.org/10.1016/j.urolonc.2011.01.018
 A. A. Ajape, K. O. Ibrahim, J. A. Fakeye and O. O. Abiola, “An Overview of Cancer of the Prostate Diagnosis and Management in Nigeria: The Experience in a Nigerian Tertiary Hospital,” Annals of African Medicine, Vol. 9, No. 3, 2010, pp. 113-117. http://dx.doi.org/10.4103/1596-3519.68353
 L. Niang, M. Ndoye, A. Ouattara, M. Jalloh, M. Labou, I. Thiam, S. C. Kouka, J. J. Diaw and S. M. Gueye, “Management of Prostate Cancer in Senegal: What Is Being Done?” Progrès en Urologie, Vol. 23, No. 1, 2013, pp. 36-41. http://dx.doi.org/10.1016/j.purol.2012.09.002
 D. C. Miller, M. S. Litwin, J. Bergman, et al., “Prostate Cancer Severity among Low Income, Uninsured Men,” The Journal of Urology, Vol. 181, No. 2, 2009, pp. 579-584.
 D. C. Greenberg, K. A. Wright, A. Lophathanon, K. R. Muir and V. J. Gnanapragasam, “Changing Presentation of Prostate Cancer in a UK Population—10 Years Trends in Prostate Cancer Risk Profiles in the East of England,” British Journal of Cancer, Vol. 109, 2013, pp. 2115-2120.
 M. J. Roobol and F. H. Schröder, “European Randomized Study of Screening for Prostate Cancer: Achievements and Presentation,” BJU International, Vol. 92, Suppl. S2, 2003, pp. 117-122.
 B. A. Virnig, N. N. Baxter, E. B. Habermann, et al., “A Matter of race: Earlyversus Late-Stage Cancer Diagnosis,” Health Affairs (Millwood), Vol. 28, No. 1, 2009, pp. 160-168.
 I. J. Powell, C. H. Bock, J. J. Ruterbusch, et al., “Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality Disparity,” The Journal of Urology, Vol. 183, No. 5, 2010, pp. 1792-1796. http://dx.doi.org/10.1016/j.juro.2010.01.015
 S. M. Gueye, C. M. Ziegler-Johnson, T. Friebel, et al., “Clinical Characteristics of Prostate Cancer in African Americans, American Whites, and Senegalese Men,” Urology, Vol. 61, No. 5, 2003, pp. 987-992. http://dx.doi.org/10.1016/S0090-4295(02)02588-8
 K. Yamoah, K. Beecham, S. E. Hegarty, T. Hyslop, T. Showalter and J. Yarney, “Early Results of Prostate Cancer Radiation Therapy: An Analysis with Emphasis on Research Strategies to Improve Treatment Delivery and Outcomes,” BMC Cancer, Vol. 13, 2013, p. 23.
 K. A. Cooney, M. S. Strawderman, K. J. Wojno, K. M. Doerr, A. Taylor, K. H. Alcser, S. G. Heeringa, J. M. Taylor, J. T. Wei, J. E. Montie and D. Schottenfeld, “Age-Specific Distribution of Serum Prostate-Specific Antigen in a Community-Based Study of African-American Men,” Urology, Vol. 57, No. 1, 2001, pp. 91-96. http://dx.doi.org/10.1016/S0090-4295(00)00873-6
 D. M. Preston, L. I. Levin, D. J. Jacobson, et al., “Prostate-Specifc Antigen Levels in Young White and Black Men 20 to 45 Years Old,” Urology, Vol. 56, No. 5, 2000, pp. 812-816.
 S. Sutcliffe, R. Pakpahan, L. J. Sokoll, D. J. Elliott, R. L. Nevin, S. B. Cersovsky, P. C. Walsh and E. A. Platz, “Prostate-Specifc Antigen Concentration in Young Men: New Estimates and Review of the Literature,” BJU International, Vol. 110, No. 11, 2012, pp. 1627-1635.
 C. F. Heyns, M. Fisher, A. Lecuona and A. van der Merwe, “Prostate Cancer among Different Racial Groups in the Western Cape: Presenting Features and Management,” South African Medical Journal, Vol. 101, 2011, pp. 267-270.
 S. A. Fedewa and A. Jemal, “Prostate Cancer Disease Severity and Country of Origin among Black Men in the United States,” Prostate Cancer and Prostatic Disease, Vol. 16, 2013, pp. 176-180.
 M. Grossmann, A. S. Cheung and J. D. Zajac, “Androgens and Prostate Cancer; Pathogenesis and Deprivation Therapy,” Best Practice & Research Clinical Endocrinology & Metabolism, Vol. 27, No. 4, 2013, pp. 603-616. http://dx.doi.org/10.1016/j.beem.2013.05.001
 C. J. DiBlasio, J. B. Malcolm, J. Hammett, J. Y. Wan, M. A. Aleman, A. L. Patterson, R. W. Wake and I. H. Derweesh, “Survival Outcomes in Men Receiving Androgendeprivation Therapy as Primary or Salvage Treatment for Localized or Advanced Prostate Cancer: 20-Year Single-Centre Experience,” BJU International, Vol. 104, No. 9, 2009, pp. 1208-1214.
 M. Y. Kyei, E. J. Mensah, S. Gepi-Attee, D. Kwami, K. Ampadu, E. Asante, G. O. Klufio and E. D. Yeboah, “Outcomes after Radical Prostatectomy in Ghanaians: A Surgeon’s Early Experience,” ISRN Urology, Vol. 2013, 2013, Article ID: 832496.
 P. C. Walsh, “Radical Prostatectomy for Localized Prostate Cancer Provides Durable Cancer Control with Excellent Quality of Life: A Structured Debate,” The Journal of Urology, Vol. 163, No. 6, 2000, pp. 1802-1807. http://dx.doi.org/10.1016/S0022-5347(05)67547-7